Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Shared genetic architecture between schizophrenia and subcortical brain volumes implicates early neurodevelopmental processes and brain development in childhood

Abstract

Patients with schizophrenia have consistently shown brain volumetric abnormalities, implicating both etiological and pathological processes. However, the genetic relationship between schizophrenia and brain volumetric abnormalities remains poorly understood. Here, we applied novel statistical genetic approaches (MiXeR and conjunctional false discovery rate analysis) to investigate genetic overlap with mixed effect directions using independent genome-wide association studies of schizophrenia (n = 130,644) and brain volumetric phenotypes, including subcortical brain and intracranial volumes (n = 33,735). We found brain volumetric phenotypes share substantial genetic variants (74–96%) with schizophrenia, and observed 107 distinct shared loci with sign consistency in independent samples. Genes mapped by shared loci revealed (1) significant enrichment in neurodevelopmental biological processes, (2) three co-expression clusters with peak expression at the prenatal stage, and (3) genetically imputed thalamic expression of CRHR1 and ARL17A was associated with the thalamic volume as early as in childhood. Together, our findings provide evidence of shared genetic architecture between schizophrenia and brain volumetric phenotypes and suggest that altered early neurodevelopmental processes and brain development in childhood may be involved in schizophrenia development.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Shared genetic basis between schizophrenia and eight brain volumetric phenotypes.
Fig. 2: Individual shared associations between schizophrenia and brain volumetric phenotypes and relevant gene expression patterns.
Fig. 3: The flowchart of gene-based functional analysis.
Fig. 4: Two candidate genes for schizophrenia and thalamus volume in late childhood.

Similar content being viewed by others

Code availability

The present study applied previously published approaches, of which codes are shared on public repositories: MiXeR v1.3 (https://github.com/precimed/mixer), conjFDR analysis (https://github.com/precimed/pleiofdr), PrediXcan (https://github.com/hakyimlab/PrediXcan), and S-PrediXcan (https://github.com/hakyimlab/MetaXcan).

References

  1. Anderson KK. Towards a public health approach to psychotic disorders. Lancet Public Health. 2019;4:e212–e213.

    PubMed  Google Scholar 

  2. Hjorthøj C, Stürup AE, McGrath JJ, Nordentoft M. Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis. Lancet Psychiatry. 2017;4:295–301.

    PubMed  Google Scholar 

  3. Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry. 1987;44:660–9.

    CAS  PubMed  Google Scholar 

  4. Carlsson M, Carlsson A. Schizophrenia: a subcortical neurotransmitter imbalance syndrome? Schizophr Bull. 1990;16:425–32.

    CAS  PubMed  Google Scholar 

  5. Laviolette SR. Dopamine modulation of emotional processing in cortical and subcortical neural circuits: evidence for a final common pathway in schizophrenia? Schizophr Bull. 2007;33:971–81.

    PubMed  PubMed Central  Google Scholar 

  6. Ghahremani DG, Lee B, Robertson CL, Tabibnia G, Morgan AT, De Shetler N, et al. Striatal dopamine D2/D3 receptors mediate response inhibition and related activity in frontostriatal neural circuitry in humans. J Neurosci. 2012;32:7316–24.

    CAS  PubMed  PubMed Central  Google Scholar 

  7. van Erp TGM, Hibar DP, Rasmussen JM, Glahn DC, Pearlson GD, Andreassen OA, et al. Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Mol Psychiatry. 2016;21:547–53.

    PubMed  Google Scholar 

  8. Boos HB, Aleman A, Cahn W, Hulshoff Pol H, Kahn RS. Brain volumes in relatives of patients with schizophrenia: a meta-analysis. Arch Gen Psychiatry. 2007;64:297–304.

    PubMed  Google Scholar 

  9. McIntosh AM, Owens DC, Moorhead WJ, Whalley HC, Stanfield AC, Hall J, et al. Longitudinal volume reductions in people at high genetic risk of schizophrenia as they develop psychosis. Biol Psychiatry. 2011;69:953–8.

    PubMed  Google Scholar 

  10. Alnæs D, Kaufmann T, van der Meer D, Córdova-Palomera A, Rokicki J, Moberget T, et al. Brain heterogeneity in schizophrenia and its association with polygenic risk. JAMA Psychiatry. 2019;76:739–48.

    PubMed  PubMed Central  Google Scholar 

  11. Trubetskoy V, Pardiñas AF, Qi T, Panagiotaropoulou G, Awasthi S, Bigdeli TB, et al. Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature 2022;604:502–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Zhao B, Luo T, Li T, Li Y, Zhang J, Shan Y, et al. Genome-wide association analysis of 19,629 individuals identifies variants influencing regional brain volumes and refines their genetic co-architecture with cognitive and mental health traits. Nat Genet. 2019;51:1637–44.

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Franke B, Stein JL, Ripke S, Anttila V, Hibar DP, van Hulzen KJE, et al. Genetic influences on schizophrenia and subcortical brain volumes: large-scale proof of concept. Nat Neurosci. 2016;19:420–31.

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Ohi K, Shimada T, Kataoka Y, Yasuyama T, Kawasaki Y, Shioiri T, et al. Genetic correlations between subcortical brain volumes and psychiatric disorders. Br J Psychiatry: J Ment Sci. 2020; 216:280–3.

    Google Scholar 

  15. Frei O, Holland D, Smeland OB, Shadrin AA, Fan CC, Maeland S, et al. Bivariate causal mixture model quantifies polygenic overlap between complex traits beyond genetic correlation. Nat Commun. 2019;10:2417.

    PubMed  PubMed Central  Google Scholar 

  16. Andreassen OA, Djurovic S, Thompson WK, Schork AJ, Kendler KS, O’Donovan MC, et al. Improved detection of common variants associated with schizophrenia by leveraging pleiotropy with cardiovascular-disease risk factors. Am J Hum Genet. 2013;92:197–209.

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Andreassen OA, Thompson WK, Dale AM. Boosting the power of schizophrenia genetics by leveraging new statistical tools. Schizophr Bull. 2014;40:13–17.

    PubMed  Google Scholar 

  18. Smeland OB, Frei O, Dale AM, Andreassen OA. The polygenic architecture of schizophrenia—rethinking pathogenesis and nosology. Nat Rev Neurol. 2020;16:366–79.

    PubMed  Google Scholar 

  19. Smeland OB, Wang Y, Frei O, Li W, Hibar DP, Franke B, et al. Genetic overlap between schizophrenia and volumes of hippocampus, putamen, and intracranial volume indicates shared molecular genetic mechanisms. Schizophr Bull. 2018;44:854–64.

    PubMed  Google Scholar 

  20. Chen J, Calhoun VD, Lin D, Perrone-Bizzozero NI, Bustillo JR, Pearlson GD, et al. Shared genetic risk of schizophrenia and gray matter reduction in 6p22.1. Schizophr Bull. 2019;45:222–32.

    PubMed  Google Scholar 

  21. van der Meer D, Shadrin AA, O’Connell K, Bettella F, Djurovic S, Wolfers T, et al. Boosting schizophrenia genetics by utilizing genetic overlap with brain morphology. Biol Psychiatry 2022;92:291–8.

    CAS  PubMed  Google Scholar 

  22. Cheng W, Frei O, van der Meer D, Wang Y, O’Connell KS, Chu Y, et al. Genetic association between schizophrenia and cortical brain surface area and thickness. JAMA Psychiatry. 2021;78:1020–30.

    PubMed  Google Scholar 

  23. Lam M, Chen C-Y, Li Z, Martin AR, Bryois J, Ma X, et al. Comparative genetic architectures of schizophrenia in East Asian and European populations. Nat Genet. 2019;51:1670–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  24. Hibar DP, Stein JL, Renteria ME, Arias-Vasquez A, Desrivières S, Jahanshad N, et al. Common genetic variants influence human subcortical brain structures. Nature 2015;520:224–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  25. Yengo L, Sidorenko J, Kemper KE, Zheng Z, Wood AR, Weedon MN, et al. Meta-analysis of genome-wide association studies for height and body mass index in 700000 individuals of European ancestry. Hum Mol Genet. 2018;27:3641–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Casey BJ, Cannonier T, Conley MI, Cohen AO, Barch DM, Heitzeg MM, et al. The Adolescent Brain Cognitive Development (ABCD) study: Imaging acquisition across 21 sites. Dev Cogn Neurosci. 2018;32:43–54.

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Kowalski MH, Qian H, Hou Z, Rosen JD, Tapia AL, Shan Y, et al. Use of >100,000 NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium whole genome sequences improves imputation quality and detection of rare variant associations in admixed African and Hispanic/Latino populations. PLOS Genet. 2019;15:e1008500.

    PubMed  PubMed Central  Google Scholar 

  28. Volkow ND, Koob GF, Croyle RT, Bianchi DW, Gordon JA, Koroshetz WJ, et al. The conception of the ABCD study: From substance use to a broad NIH collaboration. Dev Cogn Neurosci. 2018;32:4–7.

    PubMed  Google Scholar 

  29. Holland D, Frei O, Desikan R, Fan C-C, Shadrin AA, Smeland OB, et al. Beyond SNP heritability: Polygenicity and discoverability of phenotypes estimated with a univariate Gaussian mixture model. PLOS Genet. 2020;16:e1008612.

    CAS  PubMed  PubMed Central  Google Scholar 

  30. Watanabe K, Taskesen E, van Bochoven A, Posthuma D. Functional mapping and annotation of genetic associations with FUMA. Nat Commun. 2017;8:1826.

    PubMed  PubMed Central  Google Scholar 

  31. Quinlan AR, Hall IM. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 2010;26:841–2.

    CAS  PubMed  PubMed Central  Google Scholar 

  32. The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans. Science 2015;348:648–60.

  33. Kircher M, Witten DM, Jain P, O’Roak BJ, Cooper GM, Shendure J. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet. 2014;46:310–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  34. Ripke S, Neale BM, Corvin A, Walters JTR, Farh K-H, Holmans PA, et al. Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014;511:421–7.

    CAS  PubMed Central  Google Scholar 

  35. Liberzon A, Birger C, Thorvaldsdóttir H, Ghandi M, Mesirov JP, Tamayo P. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1:417–25.

    CAS  PubMed  PubMed Central  Google Scholar 

  36. Johnson NL, Kemp AW, Kotz S. Univariate discrete distributions, vol. 444. John Wiley & Sons 2005.

  37. Li M, Santpere G, Imamura Kawasawa Y, Evgrafov OV, Gulden FO, Pochareddy S, et al. Integrative functional genomic analysis of human brain development and neuropsychiatric risks. Science 2018;362:eaat7615.

    CAS  PubMed  PubMed Central  Google Scholar 

  38. Gamazon ER, Wheeler HE, Shah KP, Mozaffari SV, Aquino-Michaels K, Carroll RJ, et al. A gene-based association method for mapping traits using reference transcriptome data. Nat Genet. 2015;47:1091–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  39. Barbeira AN, Dickinson SP, Bonazzola R, Zheng J, Wheeler HE, Torres JM, et al. Exploring the phenotypic consequences of tissue-specific gene expression variation inferred from GWAS summary statistics. Nat Commun. 2018;9:1825.

    PubMed  PubMed Central  Google Scholar 

  40. BrainSeq: Neurogenomics to drive novel target discovery for neuropsychiatric disorders. Neuron 2015;88:1078–83.

  41. Fromer M, Roussos P, Sieberts SK, Johnson JS, Kavanagh DH, Perumal TM, et al. Gene expression elucidates functional impact of polygenic risk for schizophrenia. Nat Neurosci. 2016;19:1442–53.

    CAS  PubMed  PubMed Central  Google Scholar 

  42. Collado-Torres L, Burke EE, Peterson A, Shin J, Straub RE, Rajpurohit A, et al. Regional heterogeneity in gene expression, regulation, and coherence in the frontal cortex and hippocampus across development and schizophrenia. Neuron 2019;103:203–e208.

    CAS  PubMed  PubMed Central  Google Scholar 

  43. Bulik-Sullivan B, Finucane HK, Anttila V, Gusev A, Day FR, Loh P-R, et al. An atlas of genetic correlations across human diseases and traits. Nat Genet. 2015;47:1236–41.

    CAS  PubMed  PubMed Central  Google Scholar 

  44. Maurano MT, Humbert R, Rynes E, Thurman RE, Haugen E, Wang H, et al. Systematic localization of common disease-associated variation in regulatory DNA. Science 2012;337:1190–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  45. Kim M, Haney JR, Zhang P, Hernandez LM, Wang L-K, Perez-Cano L, et al. Brain gene co-expression networks link complement signaling with convergent synaptic pathology in schizophrenia. Nat Neurosci. 2021;24:799–809.

    CAS  PubMed  PubMed Central  Google Scholar 

  46. Carpenter AE, Sabatini DM. Systematic genome-wide screens of gene function. Nat Rev Genet. 2004;5:11–22.

    CAS  PubMed  Google Scholar 

  47. Jaffe AE, Straub RE, Shin JH, Tao R, Gao Y, Collado-Torres L, et al. Developmental and genetic regulation of the human cortex transcriptome illuminate schizophrenia pathogenesis. Nat Neurosci. 2018;21:1117–25.

    CAS  PubMed  PubMed Central  Google Scholar 

  48. Luo Q, Chen Q, Wang W, Desrivières S, Quinlan EB, Jia T, et al. Association of a schizophrenia-risk nonsynonymous variant with putamen volume in adolescents: a voxelwise and genome-wide association study. JAMA Psychiatry. 2019;76:435–45.

    PubMed  PubMed Central  Google Scholar 

  49. Matoba N, Love MI, Stein JL. Evaluating brain structure traits as endophenotypes using polygenicity and discoverability. Hum Brain Mapp. 2020;43:329–40.

    PubMed  PubMed Central  Google Scholar 

  50. Fanous AH, Kendler KS. Genetic heterogeneity, modifier genes, and quantitative phenotypes in psychiatric illness: searching for a framework. Mol Psychiatry. 2005;10:6–13.

    CAS  PubMed  Google Scholar 

  51. Meer DVD, Kaufmann T, Shadrin AA, Makowski C, Frei O, Roelfs D, et al. The genetic architecture of human cortical folding. Sci Adv. 2021;7:eabj9446.

    PubMed  PubMed Central  Google Scholar 

  52. Farkas LM, Huttner WB. The cell biology of neural stem and progenitor cells and its significance for their proliferation versus differentiation during mammalian brain development. Curr Opin Cell Biol. 2008;20:707–15.

    CAS  PubMed  Google Scholar 

  53. Oitzl MS, Champagne DL, van der Veen R, de Kloet ER. Brain development under stress: hypotheses of glucocorticoid actions revisited. Neurosci Biobehav Rev. 2010;34:853–66.

    CAS  PubMed  Google Scholar 

  54. Howes OD, Murray RM. Schizophrenia: an integrated socio developmental-cognitive model. Lancet 2014;383:1677–87.

    PubMed  Google Scholar 

  55. Seixas E, Barros M, Seabra MC, Barral DCRab. and Arf proteins in genetic diseases. Traffic 2013;14:871–85.

    CAS  PubMed  Google Scholar 

  56. Pfenninger KH. Plasma membrane expansion: a neuron’s Herculean task. Nat Rev Neurosci. 2009;10:251–61.

    CAS  PubMed  Google Scholar 

  57. Pantelis C, Velakoulis D, McGorry PD, Wood SJ, Suckling J, Phillips LJ, et al. Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet 2003;361:281–8.

    PubMed  Google Scholar 

  58. Kirov G, Rees E, Walters JTR, Escott-Price V, Georgieva L, Richards AL, et al. The penetrance of copy number variations for schizophrenia and developmental delay. Biol Psychiatry. 2014;75:378–85.

    CAS  PubMed  Google Scholar 

  59. Warland A, Kendall KM, Rees E, Kirov G, Caseras X. Schizophrenia-associated genomic copy number variants and subcortical brain volumes in the UK Biobank. Mol Psychiatry. 2020;25:854–62.

    CAS  PubMed  Google Scholar 

  60. Mallard TT, Liu S, Seidlitz J, Ma Z, Moraczewski D, Thomas A, et al. X-chromosome influences on neuroanatomical variation in humans. Nat Neurosci. 2021;24:1216–24.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank the Psychiatric Genetics Consortium (PGC, https://www.med.unc.edu/pgc/), the UK biobank (https://www.ukbiobank.ac.uk/), the Enhancing NeuroImaging Genetics through Meta-Analysis (ENIGMA, http://enigma.ini.usc.edu/) consortium for access to GWAS data, as well as Adolescent Brain Cognitive Development (ABCD) Study (https://abcdstudy.org) for access to genotype and brain imaging data. We thank all participants and employees of PGC, UK biobank (Application ID 27412), and ENIGMA, ABCD for their contribution to this study. The ABCD Study is supported by the National Institutes of Health and additional federal partners under award numbers: U01DA041022, U01DA041028, U01DA041048, U01DA041089, U01DA041106, U01DA041117, U01DA041120, U01DA041134, U01DA041148, U01DA041156, U01DA041174, U24DA041123, and U24DA041147. A full list of supporters is available at https://abcdstudy.org/federal-partners/. The authors were funded by the National Institutes of Health (grants NS057198 and EB00790), the Research Council of Norway (grants 229129, 276082, 213837, 223273, and 248980), the South-East Regional Health Authority (grant 2017–112), Stiftelsen Kristian Gerhard Jebsen (grants SKGJ-MED-008 and SKGJ-MED-021), the Psychiatric Genomics Consortium US Norway Collaboration (RCN 248980), part of convergence environment (MultiModal Mental Models [4MENT]) funded by the University of Oslo Life Science and Scientia Fellows, European Union’s Horizon 2020 Research and Innovation Active Grant (847776 CoMorMent), and European Union’s Horizon 2020 research and innovation programme (801133 Marie Skłodowska-Curie grant agreement), and have received internationalization support from UiO:Life Science. This work was performed on resources provided by Sigma2 (the National Infrastructure for High Performance Computing and Data Storage in Norway) and the TSD (Tjeneste for Sensitive Data) facilities.

Author information

Authors and Affiliations

Authors

Contributions

WQ and OA designed the study; WQ and DvdM pre-processed the data. WQ performed all analyses, with conceptual input from OA, DvdM, YW, NP, GH, and OS. All authors helped shape the research, and contributed to interpretation of results. WQ drafted the manuscript with input from OA, OS, NP, GH, and DvdM. All authors contributed to and approved the final manuscript.

Corresponding authors

Correspondence to Weiqiu Cheng or Ole A. Andreassen.

Ethics declarations

Competing interests

Dr. Andreassen reported grants from Stiftelsen Kristian Gerhard Jebsen, South-East Regional Health Authority, Research Council of Norway, and European Union’s Horizon 2020 during the conduct of the study; personal fees from HealthLytix (stock options), Lundbeck (speaker’s honorarium), and Sunovion (speaker’s honorarium) outside the submitted work; and had a pending patent for systems and methods for identifying polymorphisms. Dr. Dale reported grants from the National Institutes of Health outside the submitted work; had a patent for US7324842 licensed to Siemens Healthineers; is a founder of and holds equity in Cortechs Labs and serves on its scientific advisory board; is a member of the scientific advisory board of Human Longevity; a member of the scientific advisory board of Healthlytix; and receives funding through a research agreement with GE Healthcare. No other disclosures were reported.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cheng, W., van der Meer, D., Parker, N. et al. Shared genetic architecture between schizophrenia and subcortical brain volumes implicates early neurodevelopmental processes and brain development in childhood. Mol Psychiatry 27, 5167–5176 (2022). https://doi.org/10.1038/s41380-022-01751-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41380-022-01751-z

This article is cited by

Search

Quick links